Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality

Authors

Matthew Morrell, Washington University School of Medicine in St. Louis
Victoria J. Fraser, Washington University School of Medicine in St. LouisFollow
Marin H. Kollef, Washington University School of Medicine in St. LouisFollow

Journal

Antimicrobial Agents and Chemotherapy

Publication Date

2005

Volume

49

Issue

9

Inclusive Pages

3640

Document Type

Open Access Publication

DOI

10.1128/AAC.49.9.3640-3645.2005

Rights and Permissions

Morrell, M., Fraser, V. J., & Kollef, M. H. (2005). Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality. Antimicrobial Agents and Chemotherapy, 49(9), 3640-3645. DOI:10.1128/AAC.49.9.3640-3645.2005

Recommended Citation

Morrell, Matthew; Fraser, Victoria J.; and Kollef, Marin H., "Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality." Antimicrobial Agents and Chemotherapy. 49, 9. 3640. (2005).
https://digitalcommons.wustl.edu/open_access_pubs/2362